Plante Moran Financial Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212 Buy
+1
New +$196 ﹤0.01% 1440
2025
Q3
– Sell
-46
Closed -$8.26K – 812
2025
Q2
$8.26K Hold
46
– – ﹤0.01% 586
2025
Q1
$7.78K Hold
46
– – ﹤0.01% 603
2024
Q4
$6.94K Hold
46
– – ﹤0.01% 642
2024
Q3
$7.14K Hold
46
– – ﹤0.01% 643
2024
Q2
$6.3K Hold
46
– – ﹤0.01% 629
2024
Q1
$6.12K Hold
46
– – ﹤0.01% 671
2023
Q4
$6.34K Hold
46
– – ﹤0.01% 620
2023
Q3
$5.61K Hold
46
– – ﹤0.01% 591
2023
Q2
$6.47K Hold
46
– – ﹤0.01% 610
2023
Q1
$6.51K Hold
46
– – ﹤0.01% 622
2022
Q4
$7.2K Hold
46
– – ﹤0.01% 619
2022
Q3
$6K Hold
46
– – ﹤0.01% 657
2022
Q2
$6K Hold
46
– – ﹤0.01% 677
2022
Q1
$6K Sell
46
-27
-37% -$3.76K ﹤0.01% 650
2021
Q4
$13K Buy
+73
New +$11.1K ﹤0.01% 632
2020
Q4
– Sell
-67
Closed -$8K – 906
2020
Q3
$8K Buy
+67
New +$7.92K ﹤0.01% 630
2020
Q1
– Sell
-366
Closed -$39K – 751
2019
Q4
$39K Hold
366
– – 0.01% 353
2019
Q3
$39K Hold
366
– – 0.01% 377
2019
Q2
$37K Buy
+366
New +$35.2K 0.01% 386
2019
Q1
– Sell
-65
Closed -$5K – 804
2018
Q4
$5K Buy
+65
New +$6.09K ﹤0.01% 592

Other funds holding DGX

Plante Moran Financial Advisors's DGX Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1 share worth $212. The stake represents ﹤0.01% of the portfolio and ranks #1440 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in DGX as recently as Q2 2025.

Plante Moran Financial Advisors first reported a position in DGX in Q4 2018 and has held it in 21 quarters since. The position peaked at $39K in Q4 2019. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Plante Moran Financial Advisors held 1 share of Quest Diagnostics worth $212 as of Q2 2026.
  • Quest Diagnostics was a new Plante Moran Financial Advisors position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1440 holding.
  • Plante Moran Financial Advisors first reported a position in Quest Diagnostics in Q4 2018 and has held it in 21 quarters since.
  • Plante Moran Financial Advisors's Quest Diagnostics position peaked at $39K in Q4 2019.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.